冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

pfizer aps - methotrexatum inn - tafla - 2,5 mg

冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

orion corporation - methotrexatum inn - tafla - 2,5 mg

冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

ebewe pharma ges.m.b.h.nfg. kg - methotrexatum inn - innrennslisþykkni, lausn - 100 mg/ml

欧盟 - 冰岛文 - EMA (European Medicines Agency)

bayer ag - darolutamide - stækkun Æxli, gelding-Þola - innkirtla meðferð - nubeqa is indicated for the treatment of adult men with- non metastatic castration resistant prostate cancer (nmcrpc) who are at high risk of developing metastatic disease (see section 5. - metastatic hormone sensitive prostate cancer (mhspc) in combination with docetaxel and androgen deprivation therapy (see section 5.

欧盟 - 冰岛文 - EMA (European Medicines Agency)

gilead sciences ireland uc - bulevirtide acetate - hepatitis d, chronic - veirueyðandi lyf til almennrar notkunar - hepcludex is indicated for the treatment of chronic hepatitis delta virus (hdv) infection in plasma (or serum) hdv-rna positive adult patients with compensated liver disease.

冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

tillotts pharma ab - mesalazinum inn - endaþarmsdreifa - 10 mg/ml

冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

tillotts pharma ab - mesalazinum inn - endaþarmsstíll - 500 mg

冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

tillotts pharma ab - mesalazinum inn - magasýruþolin tafla - 400 mg

冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

tillotts pharma ab - mesalazinum inn - magasýruþolin tafla - 800 mg

冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

tillotts pharma ab - mesalazinum inn - tafla með breyttan losunarhraða - 1600 mg